ArticleFrontiers in nutrition2025
Acute beetroot juice supplementation augments early neuromuscular performance after blood flow restriction: a crossover study in elite basketball players.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Beetroot juice (BJ), rich in nitrate, has been shown to enhance exercise performance via nitric oxide-mediated pathways. While its effects on endurance and strength have been studied, its influence on blood flow restriction (BFR)-induced post-activation potentiation (PAP) remains unclear. Methods: Twenty elite male basketball players (aged 21.25 ± 1.77 years) completed a randomized, double-blind, placebo-controlled crossover trial. Participants ingested BJ (8.4 mmol nitrate) or placebo before performing a standardized warm-up and BFR-assisted plyometric protocol. Counter-movement jump (CMJ) variables were recorded at baseline and at 0, 4-, 8-, 12-, and 16-min post-intervention. A two-way repeated-measures ANOVA was used to assess condition, time, and interaction effects, supplemented by Bonferroni-corrected paired Results: BJ significantly increased jump height calculated from take-off velocity [H(v)], peak power (PP), and peak rate of force development (PRFD) during the first 8 min post-intervention compared to placebo. Placebo showed higher H(v) at 12 min. Some variables showed moderate effect sizes without statistical significance, likely due to limited power. No performance benefits were observed in either condition at 16 min. Conclusion: Acute BJ intake synergizes with BFR-induced PAP to transiently enhance neuromuscular performance, particularly within an early 8-min window. However, the effects are time-sensitive and may not extend or outperform placebo at later stages. These findings support a targeted, time-optimized use of BJ in warm-up strategies for explosive performance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.